Drug Controller Gives Conditional Market Approval To Covishield, Covaxin
- By Shachi Sutaria | 27 Jan 2022 1:56 PM GMT
Bharat Biotech Finally Publishes Covaxin Phase III Data, 77% Efficacy
- By Shachi Sutaria | 12 Nov 2021 12:23 PM GMT
Explained: Why Bharat Biotech Ended Covaxin Deal With Brazil Manufacturer
- By Shachi Sutaria | 24 July 2021 3:49 PM GMT
Covaxin 77.8% Effective Against COVID-19, Claims Phase 3 Data
- By Shachi Sutaria | 3 July 2021 9:19 AM GMT
Explained: Why Brazil Suspended $324 Mn Deal With Covaxin
- By Shachi Sutaria | 1 July 2021 1:44 PM GMT
Bharat Biotech Denies Reports Of Sharing Phase 3 Covaxin Data With WHO
- By Shachi Sutaria | 18 Jun 2021 8:59 AM GMT
Health Ministry, Bharat Biotech Deny Covaxin Has New Born Calf Serum
- By Shachi Sutaria | 16 Jun 2021 11:07 AM GMT
Why India's Homegrown Covaxin Faced Rejection From US FDA
- By Shachi Sutaria | 11 Jun 2021 11:58 AM GMT
Bharat Biotech Says Covaxin Shows 81% Efficacy In Phase 3 Interim Results
- By Shachi Sutaria | 3 March 2021 1:21 PM GMT
2018 News Clipping On Measles Vaccine Side Effects Linked To COVID
- By Sk Badiruddin | 22 Jan 2021 8:49 AM GMT
COVID-19 Vaccine Tracker: India To Begin Vaccination For 18-45 From May 1
- By Shachi Sutaria | 13 Jan 2021 4:36 AM GMT
COVID-19 Vaccine Fiasco Shows Regulators Not Following Rules: Experts | Watch Video
- By Govindraj Ethiraj | 6 Jan 2021 5:10 AM GMT
